Edition:
India

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

28.43USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$28.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
64,464
52-wk High
$40.56
52-wk Low
$19.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 9.77 12.50 7.05 --
Quarter Ending Jun-18 2 9.77 12.50 7.05 --
Year Ending Dec-18 7 47.01 50.50 28.18 39.14
Earnings (per share)
Quarter Ending Mar-18 4 -0.57 -0.45 -0.78 --
Quarter Ending Jun-18 4 -0.57 -0.42 -0.73 --
Year Ending Dec-18 8 -2.42 -1.58 -2.97 -1.61
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.95%
# of Holders: 124
Total Shares Held: 10,307,512
3 Mo. Net Change: -325,293
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 11
# Reduced Positions: 9
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.